Company Information
Company Profile
Cash Flow Statement
Profit & Loss
Financial Position
Financial Ratio
Industry 制造业
Company Introduction 天津瑞普生物技术股份有限公司是一家具有原始创新能力,集兽用生物制品和兽用制剂研发、生产、销售和技术服务于一体的高新技术企业.公司产品包括兽用生物制品和兽用制剂两大类276个品种,产品丰富、结构合理.公司主要产品在细分市场位居行业前列,其中鸡新城疫灭活疫苗(LaSota株),鸡新城疫耐热保护剂活疫苗(LaSota株),鸡新城疫、传染性支气管炎二联活疫苗(LaSota+H120株),鸡传染性法氏囊病活疫苗(B87株),鸡传染性法氏囊病耐热保护剂活疫苗(B87株)五种产品2008年产销量均列行业单品前五名.公司为国内少数几家产品覆盖动物疫病预防、诊断、治疗、促生长以及调节免疫机制的兽药企业之一。
Main Business 兽用生物制品、兽用药物制剂（化学药品、中兽药、消毒剂等）、兽用原料药、兽用功能性添加剂的研发、生产、销售及动物疫病整体防治解决方案的提供。
Legal Representative 李守军
Top Executives
董事长：李守军
董事：徐雷,李睿,刘爱玲,朱秀同,杨鶄
独立董事：才学鹏,郭春林,李娅
Top 5 Shareholder
Shareholder name Nature Holding Date
李守军限售股+流通A股35.95%31/03/2025
梁武流通A股5.09%31/03/2025
鲍恩东流通A股2.40%31/03/2025
苏雅拉达来流通A股2.36%31/03/2025
中国建设银行股份有限公司－嘉实农业产业股票型证券投资基金流通A股1.37%31/03/2025
Company Secretary 谢刚
Solicitors 北京市康达律师事务所
Auditors 立信会计师事务所（特殊普通合伙）
Tel No 022-88958118
Fax No 022-88958118
Website www.ringpu.com
Email zqb@ringpu.com
Company Address
Register: 天津自贸试验区（空港经济区）东九道1号
Office: 天津自贸试验区（空港经济区）东九道1号
Listing Date 17/09/2010
Shares Capital
Shares Capital: 465,847,906
Total A Share: 465,847,906
Listed A Share: 334,962,021
Non-tradable A Share: 130,885,885
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.653
DPS(RMB)* ¥ 0.300
NBV Per Share(RMB)* ¥ 9.595
Market Capitalization(RMB) 8.394B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Chiyu Banking Corporation Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.